Unknown

Dataset Information

0

Synthetic hydrogel scaffold is an effective vehicle for delivery of INFUSE (rhBMP2) to critical-sized calvaria bone defects in rats.


ABSTRACT: Medtronic's INFUSE Bone Graft provides surgeons with a potent tool for stimulating bone formation. Current delivery vehicles that rely on Absorbable Collagen Sponges (ACS) require excessive quantities of the active ingredient in INFUSE, recombinant human Bone Morphogenic Protein-2 (rhBMP2), to achieve physiologically relevant concentrations of the growth factor, driving up the cost of the product and increasing the likelihood of undesirable side effects in neighboring tissues. We demonstrate that a simple light-mediated, thiol-ene chemistry can be used to create an effective polymer delivery vehicle for rhBMP2, eliminating the use of xenographic materials and reducing the dose of rhBMP2 required to achieve therapeutic effects. Comprised entirely of synthetic components, this system entraps rhBMP2 within a biocompatible hydrogel scaffold that is degraded by naturally occurring remodeling enzymes, clearing the way for new tissue formation. When tested side-by-side with ACS in a critical-sized bone defect model in rats, this polymeric delivery system significantly increased bone formation over ACS controls.

SUBMITTER: Mariner PD 

PROVIDER: S-EPMC3565235 | biostudies-literature | 2013 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthetic hydrogel scaffold is an effective vehicle for delivery of INFUSE (rhBMP2) to critical-sized calvaria bone defects in rats.

Mariner Peter D PD   Wudel Justin M JM   Miller David E DE   Genova E Erin EE   Streubel Sven-Olrik SO   Anseth Kristi S KS  

Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20121015 3


Medtronic's INFUSE Bone Graft provides surgeons with a potent tool for stimulating bone formation. Current delivery vehicles that rely on Absorbable Collagen Sponges (ACS) require excessive quantities of the active ingredient in INFUSE, recombinant human Bone Morphogenic Protein-2 (rhBMP2), to achieve physiologically relevant concentrations of the growth factor, driving up the cost of the product and increasing the likelihood of undesirable side effects in neighboring tissues. We demonstrate tha  ...[more]

Similar Datasets

| S-EPMC8245198 | biostudies-literature
| S-EPMC6981995 | biostudies-literature
| S-EPMC5689752 | biostudies-literature
| S-EPMC5332017 | biostudies-literature
| S-EPMC4735608 | biostudies-literature
| S-EPMC8091496 | biostudies-literature
| S-EPMC7072084 | biostudies-literature
| S-EPMC3029004 | biostudies-literature
| S-EPMC7049411 | biostudies-literature
| S-EPMC6213059 | biostudies-literature